Metformin and dietary advice to improve insulin sensitivity and promote gestational restriction of weight in pregnant women who are overweight or obese: the GroW Randomised trial.

Not Applicable

Completed

• Conditions: High birth weight of infants of obese pregnant women; Reproductive Health and Childbirth - Other reproductive health and childbirth disorders; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12612001277831
• Lead Sponsor: The University of Adelaide

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-12-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 524

Inclusion Criteria

Women with a singleton, live gestation between 10 +0 and 20 +0 weeks gestation with a BMI above or equal to 25 kg/m2 at their first antenatal visit.

Exclusion Criteria

Women with a multiple pregnancy, type 1 or 2 diabetes diagnosed prior to pregnancy, known renal or hepatic failure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in risk of infant being born with birth weight above 4.0 kg[At birth]